Grifols S.A.

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition gptkb:Biotest_AG
gptkb:Talecris_Biotherapeutics
GigaGen
gptkbp:CEO Victor Grifols Deu
gptkbp:clinicalTrials multiple ongoing studies
gptkbp:employees over 24,000
gptkbp:focus Research and development
gptkbp:founded 1940
gptkbp:founder gptkb:Victor_Grifols_Roura
gptkbp:globalPresence over 30 countries
gptkbp:headquarters gptkb:Barcelona,_Spain
https://www.w3.org/2000/01/rdf-schema#label Grifols S.A.
gptkbp:industry Pharmaceuticals
gptkbp:market €10 billion (2021)
gptkbp:partnerships gptkb:University_of_Barcelona
gptkb:University_of_Ottawa
gptkb:Bristol-Myers_Squibb
gptkb:Harvard_University
gptkb:Johns_Hopkins_University
gptkb:Stanford_University
gptkb:University_of_British_Columbia
gptkb:University_of_Calgary
gptkb:University_of_Michigan
gptkb:University_of_Pennsylvania
gptkb:University_of_Toronto
gptkb:University_of_Washington
gptkb:University_of_Manitoba
gptkb:McGill_University
gptkb:University_of_California,_San_Diego
gptkb:University_of_Melbourne
gptkb:University_of_Queensland
gptkb:University_of_Southern_California
gptkb:University_of_Sydney
gptkb:University_of_Texas
gptkb:University_of_New_South_Wales
gptkb:Simon_Fraser_University
gptkb:University_of_Alberta
gptkb:University_of_Saskatchewan
gptkb:Scripps_Research_Institute
gptkb:University_of_Victoria
Kedrion Biopharma
gptkbp:philanthropy gptkb:Grifols_Foundation
gptkbp:productLine Factor VIII
Albumin
IVIG
Plasma collection systems
Hyperimmune_globulins
gptkbp:products Plasma-derived medicines
gptkbp:revenue €5.3 billion (2020)
gptkbp:stockExchange gptkb:NASDAQ
gptkbp:subsidiary gptkb:Grifols_Diagnostic_Solutions
Grifols Biologicals